179 related articles for article (PubMed ID: 28849353)
1. Equivalent Treatment and Survival after Resection of Pancreatic Cancer at Safety-Net Hospitals.
Dhar VK; Hoehn RS; Kim Y; Xia BT; Jung AD; Hanseman DJ; Ahmad SA; Shah SA
J Gastrointest Surg; 2018 Jan; 22(1):98-106. PubMed ID: 28849353
[TBL] [Abstract][Full Text] [Related]
2. Opportunities to Improve Care of Hepatocellular Carcinoma in Vulnerable Patient Populations.
Hoehn RS; Hanseman DJ; Dhar VK; Go DE; Edwards MJ; Shah SA
J Am Coll Surg; 2017 Apr; 224(4):697-704. PubMed ID: 28069526
[TBL] [Abstract][Full Text] [Related]
3. Patient Factors Limit Colon Cancer Survival at Safety-Net Hospitals: A National Analysis.
Hrebinko KA; Rieser C; Nassour I; Tohme S; Sabik LM; Khan S; Medich DS; Zureikat AH; Hoehn RS
J Surg Res; 2021 Aug; 264():279-286. PubMed ID: 33839343
[TBL] [Abstract][Full Text] [Related]
4. Liver transplantation at safety net hospitals: Potentially vulnerable patients with noninferior outcomes.
Lee TC; Dhar VK; Hoehn RS; Wima K; Kim Y; Ertel AE; Patel SH; Shah SA
Surgery; 2019 Dec; 166(6):1135-1141. PubMed ID: 31375321
[TBL] [Abstract][Full Text] [Related]
5. Association between hospital safety-net burden and receipt of trimodality therapy and survival for patients with esophageal cancer.
Qureshi MM; Kam A; Suzuki K; Litle V; Tapan U; Balasubramaniyan R; Dyer MA; Truong MT; Mak KS
Surgery; 2023 May; 173(5):1153-1161. PubMed ID: 36774317
[TBL] [Abstract][Full Text] [Related]
6. Differences in emergency colorectal surgery in Medicaid and uninsured patients by hospital safety net status.
Bradley CJ; Dahman B; Sabik LM
Am J Manag Care; 2015 Feb; 21(2):e161-70. PubMed ID: 25880490
[TBL] [Abstract][Full Text] [Related]
7. Management of glioblastoma at safety-net hospitals.
Brandel MG; Rennert RC; Lopez Ramos C; Santiago-Dieppa DR; Steinberg JA; Sarkar RR; Wali AR; Pannell JS; Murphy JD; Khalessi AA
J Neurooncol; 2018 Sep; 139(2):389-397. PubMed ID: 29691776
[TBL] [Abstract][Full Text] [Related]
8. Cardiorespiratory morbidity and mortality of opioid overdose during admission to safety-net hospitals.
Burton BN; Labastide AS; Meineke MN; Schmidt UH; Gabriel RA
J Clin Anesth; 2019 May; 54():66-71. PubMed ID: 30408618
[TBL] [Abstract][Full Text] [Related]
9. Nationwide trends and outcomes associated with neoadjuvant therapy in pancreatic cancer: An analysis of 18 243 patients.
Youngwirth LM; Nussbaum DP; Thomas S; Adam MA; Blazer DG; Roman SA; Sosa JA
J Surg Oncol; 2017 Aug; 116(2):127-132. PubMed ID: 28407261
[TBL] [Abstract][Full Text] [Related]
10. Safety-net burden hospitals and likelihood of curative-intent surgery for non-small cell lung cancer.
Virgo KS; Little AG; Fedewa SA; Chen AY; Flanders WD; Ward EM
J Am Coll Surg; 2011 Nov; 213(5):633-43. PubMed ID: 21907598
[TBL] [Abstract][Full Text] [Related]
11. Colorectal Cancer Safety Net: Is It Catching Patients Appropriately?
Althans AR; Brady JT; Times ML; Keller DS; Harvey AR; Kelly ME; Patel ND; Steele SR
Dis Colon Rectum; 2018 Jan; 61(1):115-123. PubMed ID: 29219921
[TBL] [Abstract][Full Text] [Related]
12. Initiation of adjuvant therapy following surgical resection of pancreatic ductal adenocarcinoma (PDAC): Are patients from rural, remote areas disadvantaged?
Bertens KA; Massman JD; Helton S; Garbus S; Mandelson MM; Lin B; Picozzi VJ; Biehl T; Alseidi AA; Rocha FG
J Surg Oncol; 2018 Jun; 117(8):1655-1663. PubMed ID: 29761510
[TBL] [Abstract][Full Text] [Related]
13. Impact of Race, Insurance Status, and Primary Language on Presentation, Treatment, and Outcomes of Patients with Pancreatic Adenocarcinoma at a Safety-Net Hospital.
Sridhar P; Misir P; Kwak H; deGeus SW; Drake FT; Cassidy MR; McAneny DA; Tseng JF; Sachs TE
J Am Coll Surg; 2019 Oct; 229(4):389-396. PubMed ID: 31212101
[TBL] [Abstract][Full Text] [Related]
14. Hospital safety-net burden does not predict differences in rectal cancer treatment and outcomes.
Hoehn RS; Go DE; Hanseman DJ; Shah SA; Paquette IM
J Surg Res; 2018 Jan; 221():204-210. PubMed ID: 29229129
[TBL] [Abstract][Full Text] [Related]
15. Disparities in pancreas cancer care.
Abraham A; Al-Refaie WB; Parsons HM; Dudeja V; Vickers SM; Habermann EB
Ann Surg Oncol; 2013 Jun; 20(6):2078-87. PubMed ID: 23579872
[TBL] [Abstract][Full Text] [Related]
16. Utilization and determinants of adjuvant therapy among older patients who receive curative surgery for pancreatic cancer.
Davila JA; Chiao EY; Hasche JC; Petersen NJ; McGlynn KA; Shaib YH
Pancreas; 2009 Jan; 38(1):e18-25. PubMed ID: 18797424
[TBL] [Abstract][Full Text] [Related]
17. The Importance of Safety-Net Hospitals in Emergency General Surgery.
Dhar VK; Kim Y; Wima K; Hoehn RS; Shah SA
J Gastrointest Surg; 2018 Dec; 22(12):2064-2071. PubMed ID: 30039448
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic adenocarcinoma: effects of neoadjuvant therapy on post-pancreatectomy outcomes - an American College of Surgeons National Surgical Quality Improvement Program targeted variable review.
Czosnyka NM; Borgert AJ; Smith TJ
HPB (Oxford); 2017 Oct; 19(10):927-932. PubMed ID: 28747265
[TBL] [Abstract][Full Text] [Related]
19. Effects of hospital safety-net burden and hospital volume on failure to rescue after open abdominal aortic surgery.
Rosero EB; Joshi GP; Minhajuddin A; Timaran CH; Modrall JG
J Vasc Surg; 2017 Aug; 66(2):404-412. PubMed ID: 28433333
[TBL] [Abstract][Full Text] [Related]
20. Carbohydrate Antigen 19-9 Elevation in Anatomically Resectable, Early Stage Pancreatic Cancer Is Independently Associated with Decreased Overall Survival and an Indication for Neoadjuvant Therapy: A National Cancer Database Study.
Bergquist JR; Puig CA; Shubert CR; Groeschl RT; Habermann EB; Kendrick ML; Nagorney DM; Smoot RL; Farnell MB; Truty MJ
J Am Coll Surg; 2016 Jul; 223(1):52-65. PubMed ID: 27049786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
